Non-Recommended Cervical Cancer Screening in Adolescent Females

The percentage of adolescent females 16-20 years of age who were screened unnecessarily for cervical cancer.

Date Reviewed: November 19, 2017

Measure Info

MIPS 443 CMS 443
Measure Type
Measure Steward
National Committee for Quality Assurance
Clinical Topic Area
Cancer Screening
Prevention and Wellness
Women's Preventive Services

Care Setting
Data Source

ACP supports QPP measure 443: "Non-Recommended Cervical Cancer Screening in Adolescent Females” because implementation will likely promote appropriate use of cervical cancer screening in adolescents, the measure is well specified, and specifications include appropriate exclusion criteria for women diagnosed with HIV. Additionally, the measure aligns with United States Preventive Services Task Force (USPSTF) recommendations on cervical cancer screening. While we support this measure, current data on cervical cancer screening in women shows that earlier screening recommendations are not as effective as previously indicated in diagnosing HPV in women aged 16-20 years. The evidence base would benefit from re-evaluation as data surfaces on the benefits and risks of screening in women < 20 years old. In addition, the developers do not cite a performance gap in the measure report, and therefore, we cannot estimate the potential impact of the measure on quality outcomes.